Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 2/20 | 0.50 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.50 |
| ▸ | ESR1 | P03372 | 4/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.48 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28586676 | 0.98 | ESR1 (0.52) | HSD17B1HSD17B2ESR1ESR2CYP17A1 | |
| SCHEMBL1371905 | 0.94 | HSD17B1 (0.44) | HSD17B1HSD17B2ESR1ESR2CYP17A1 | |
| SCHEMBL2448124 | 0.93 | ESR1 (0.47) | HSD17B1HSD17B2ESR1ESR2CYP17A1 | |
| SCHEMBL6533069 | 0.86 | ESR1 (0.37) | HSD17B1HSD17B2ESR1ESR2CYP17A1 | |
| SCHEMBL19467302 | 0.86 | HSD17B1 (0.39) | HSD17B1HSD17B2ESR1ESR2CYP17A1 | |
| SCHEMBL3783466 | 0.85 | ALDH1A1 (0.45) | HSD17B1HSD17B2ESR1ESR2CYP17A1 | |
| SCHEMBL20774167 | 0.83 | ALDH1A1 (0.47) | HSD17B1HSD17B2ESR1ESR2CYP17A1 | |
| SCHEMBL9957880 | 0.83 | CYP1A1 (0.53) | HSD17B1HSD17B2CYP17A1CYP19A1CYP11B1 | |
| SCHEMBL2271000 | 0.82 | ESR1 (0.50) | HSD17B1HSD17B2ESR1ESR2CYP17A1 | |
| SCHEMBL2274784 | 0.82 | ESR1 (0.50) | HSD17B1HSD17B2ESR1ESR2CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337532-A1 | TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE | TOSOH CORPORATION (JP) | 2023-10-19 | — | — | US | claimed |
| CN-116348454-A | Triazine compound, material for organic electroluminescent element, electron-transporting material for organic electroluminescent element, and organic electroluminescent element | 东曹株式会社 | 2023-06-27 | — | — | CN | claimed |
| CN-112912372-A | Cyclic azine compound, material for organic electroluminescent element, electron transport material for organic electroluminescent element, and organic electroluminescent element | 东曹株式会社 | 2021-06-04 | — | — | CN | claimed |
| WO-2020085319-A1 | CYCLIC AZINE COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ELECTRON TRANSPORT MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | 東ソー株式会社 | 2020-04-30 | — | — | WO | claimed |
| US-10586933-B2 | Electroactive metal complexes | LG CHEM, LTD. (KR) | 2020-03-10 | — | — | US | claimed |
| US-20170012222-A1 | ELECTROACTIVE METAL COMPLEXES | LG CHEM, LTD. (KR) | 2017-01-12 | — | — | US | claimed |
| WO-2015112561-A1 | ELECTROACTIVE METAL COMPLEXES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2015-07-30 | — | — | WO | claimed |
| EP-1930329-B1 | 1,3,5-TRIAZINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME AS COMPONENT | TOSOH CORP (JP) | 2012-10-24 | — | — | EP | claimed |
| CN-101248058-B | 1, 3, 5-triazine derivative, method for producing the same and organic electroluminescent device comprising the same as constituent | TOSOH CORP | 2012-05-09 | — | — | CN | claimed |
| US-7994316-B2 | 1,3,5-triazine derivative, production method thereof and organic electroluminescence device comprising this as a composing component | TOSOH CORPORATION (JP) | 2011-08-09 | — | — | US | claimed |
| US-7560604-B2 | Biphenyl derivative, material for organic electroluminescence device, and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-07-14 | — | — | US | claimed |
| CN-101248058-A | 1, 3, 5-triazine derivative, method for producing the same and organic electroluminescent device comprising the same as constituent | TOSOH CORP (JP) | 2008-08-20 | — | — | CN | claimed |
| EP-1930329-A1 | 1,3,5-TRIAZINE DERIVATIVE, METHOD FOR PRODUCING SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING SAME AS COMPONENT | Tosoh Corporation (JP) | 2008-06-11 | — | — | EP | claimed |
| US-20060173058-A1 | Kcnq channel modulating compounds and their pharmaceutical use | NEUROSEARCH A/S (DK) | 2006-08-03 | — | — | US | claimed |
| EP-1603858-A2 | KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE | NeuroSearch A/S (DK) | 2005-12-14 | — | — | EP | claimed |
| WO-2004080377-A2 | KCNQ CHANNEL MODULATING COMPOUNDS AND THEIR PHARMACEUTICAL USE | NEUROSEARCH A/S (DK) | 2004-09-23 | — | — | WO | claimed |
| EP-0821665-B1 | CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE | ABBOTT LAB (US) | 2001-10-04 | — | — | EP | claimed |
| US-5831115-A | CYCLOBUTANECARBOXAMIDES | ABBOTT LABORATORIES (US) | 1998-11-03 | — | — | US | claimed |
| EP-0821665-A1 | CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE | Abbott Laboratories (US) | 1998-02-04 | — | — | EP | claimed |
| WO-1996033159-A1 | CYCLOBUTANE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHASE AND PROTEIN FARNESYLTRANSFERASE | ABBOTT LABORATORIES (US) | 1996-10-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10586933-B2 | Electroactive metal complexes | AFF1, AFF4, AFF2 | HSD17B1 1235/4885HSD17B2 1162/4885ESR1 15/4885 |
| US-20230337532-A1 | TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE | ARNT, TPH1, AHR | HSD17B1 842/4885HSD17B2 938/4885ESR1 423/4885 |
| US-20060173058-A1 | Kcnq channel modulating compounds and their pharmaceutical use | KCNQ1, KCNQ2, KCNQ5 | HSD17B1 4172/4885HSD17B2 3777/4885ESR1 3904/4885 |
| US-20170012222-A1 | ELECTROACTIVE METAL COMPLEXES | AFF1, AFF4, AFF2 | HSD17B1 1235/4885HSD17B2 1162/4885ESR1 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.